NanoString Technologies
NanoString Technologies Newswire

NanoString Technologies Newswire

Comprehensive Real-Time News Feed for NanoString Technologies.

Results 1 - 20 of 22 in NanoString Technologies

  1. NanoString To Present At Upcoming Investor ConferencesRead the original story

    Wednesday Aug 26 | BioSpace

    SEATTLE, Aug. 26, 2015 -- NanoString Technologies, Inc. , a provider of life science tools for translational research and molecular diagnostic products, today announced that Brad Gray, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences: Interested parties can access the live webcast with accompanying slides from the investor section of the company's website at www.nanostring.com . The webcast replay will be available one hour after the conclusion of the live presentation and archived for 90 days.

    Comment?

  2. NanoString To Present At The Growth ConferenceRead the original story

    Thursday Jul 30 | BioSpace

    NanoString Technologies, Inc. , a provider of life science tools for translational research and molecular diagnostic products, today announced that its management is scheduled to present at the Canaccord Genuity Growth Conference in Boston. Brad Gray, President and Chief Executive Officer, is scheduled to present on Thursday, August 13, 2015 at 4:00pm ET.

    Comment?

  3. NanoString CEO On How Creating A Niche Is Good For Business: Q&ARead the original story

    Jul 22, 2015 | BioSpace

    Seattle biotech NanoString Technologies is finding that being a jack of all trades isn't as valuable to business as excelling at one. The company makes diagnostic tools to help researchers and drug companies understand what goes wrong in a person's DNA that causes a cancer to develop, and how well treatments work for each individual.

    Comment?

  4. Q&A: NanoString CEO on how creating a niche is good for businessRead the original story w/Photo

    Jul 22, 2015 | Business Journal

    Seattle biotech NanoString Technologies is finding that being a jack of all trades isn't as valuable to business as excelling at one. The company makes diagnostic tools to help researchers and drug companies understand what goes wrong in a person's DNA that causes a cancer to develop, and how well treatments work for each individual.

    Comment?

  5. NanoString To Release Second Quarter 2015 Financial Results And Host...Read the original story

    Jul 21, 2015 | BioSpace

    NanoString Technologies, Inc. , a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release second quarter 2015 financial results after the close of trading on Tuesday, August 4, 2015. Company management will host a conference call beginning at 4:30pm ET to discuss those results and to provide a business update.

    Comment?

  6. NanoString Technologies launches "Dear Cancer Researchers" campaignRead the original story w/Photo

    Jul 20, 2015 | Medical News

    One of the greatest obstacles in the fight against cancer is the pace of the cancer research itself. Today, NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, launched an advertising campaign called "Dear Cancer Researchers" to unveil its industry-changing nCounter SPRINT Profiler.

    Comment?

  7. Evaluating Robustness and Sensitivity of the NanoString Technologies...Read the original story

    Jul 4, 2015 | CiteULike

    ... those isolated from FFPE tissue, remains a challenge. Here, we provide a detailed evaluation of the NanoString Technologies nCounter platform, which provides a direct digital readout of up to 800 mRNA targets simultaneously. We tested this system by ...

    Comment?

  8. New Report Available: Partek Incorporated - Pharmaceuticals &...Read the original story

    Jun 28, 2015 | PR-inside.com

    ... Inc., Applied Biosystems, Illumina, Fluidigm, Ingenuity Systems, IO Informatics, Ion Torrent, and NanoString Technologies. Partek is headquartered in Saint Louis, Missouri, the US. Full Report Details at - www ...

    Comment?

  9. Merck & Co. And NanoString Announce Clinical Research Collaboration...Read the original story

    May 27, 2015 | BioSpace

    Merck & Co. And NanoString Announce Clinical Research Collaboration To Develop An Immune-Related Gene Expression Assay For Use In The Development Program For KEYTRUDA Collaboration Builds on Merck's R&D and NanoString's Biomarker Development Leadership Positions in Immuno-Oncology Early Data Evaluating Immune-Related Signatures with KEYTRUDA in Multiple Cancers to be Presented for the First Time at 2015 ASCO Annual Meeting KENILWORTH, N.J. & SEATTLE-- --Merck , known as MSD outside the United States and Canada, and NanoString Technologies, Inc. today announced a clinical research collaboration to develop an assay that will optimize immune-related gene expression signatures and evaluate the potential to predict benefit from Merck's anti-PD-1 therapy, KEYTRUDAA , in multiple tumor types.

    Comment?

  10. NanoString Releases Financial Results For First Quarter Of 2015Read the original story

    May 6, 2015 | BioSpace

    NanoString Technologies, Inc. , a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter ended March 31, 2015. "We are off to a promising start in 2015.

    Comment?

  11. NanoString Technologies to Present at the UBS Global Healthcare ConferenceRead the original story w/Photo

    May 7, 2015 | GlobeNewswire

    NanoString Technologies, Inc. , a provider of life science tools for translational research and molecular diagnostic products, today announced that its management is scheduled to present at the UBS Global Healthcare Conference in New York. Brad Gray, President and Chief Executive Officer, is scheduled to present on Wednesday, May 20, 2015 at 8:30am ET.

    Comment?

  12. Why life sciences attracts more venture funding than biotech in SeattleRead the original story w/Photo

    Apr 28, 2015 | Business Journal

    ... s individual immune systems to better understand which drugs work on a person. Seattle-based biotech NanoString Technologies (Nasdaq: NSTG) is similar in that it develops diagnostic tools .

    Comment?

  13. Why life sciences attracts more venture funding than biotech in SeattleRead the original story w/Photo

    Apr 28, 2015 | Business Journal

    ... s individual immune systems to better understand which drugs work on a person. Seattle-based biotech NanoString Technologies (Nasdaq: NSTG) is similar in that it develops diagnostic tools .

    Comment?

  14. NanoString Technologies Stock Rating Reaffirmed by BTIG ResearchRead the original story w/Photo

    Apr 19, 2015 | AmericanBankingNews.com

    ... current price. Separately, analysts at Morgan Stanley reiterated an "overweight" rating on shares of NanoString Technologies in a research note on Tuesday, March 24th. Shares of NanoString Technologies ( NASDAQ:NSTG ) opened at 11.81 on Friday. ...

    Comment?

  15. NanoString Technologies Stock Rating Reaffirmed by BTIG ResearchRead the original story w/Photo

    Apr 19, 2015 | AmericanBankingNews.com

    ... current price. Separately, analysts at Morgan Stanley reiterated an "overweight" rating on shares of NanoString Technologies in a research note on Tuesday, March 24th. Shares of NanoString Technologies ( NASDAQ:NSTG ) opened at 11.81 on Friday. ...

    Comment?

  16. MD Anderson and NanoString Technologies announce multi-year collaborationRead the original story w/Photo

    Mar 31, 2015 | EurekAlert!

    The University of Texas MD Anderson Cancer Center and NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year collaboration to accelerate the development and adoption of a new type of assay based on NanoString's nCounter Analysis System. The collaboration will involve the development of "multi-omic" assays, which simultaneously profile both gene and protein expression, with a primary focus on identifying important biomarkers in the burgeoning field of immuno-oncology as well as extending programs for targeting therapeutics.

    Comment?

  17. Market Report, "NanoString Technologies, Inc. - Medical Equipment -...Read the original story

    Mar 5, 2015 | PR-inside.com

    2015-03-05 20:12:37 - Recently published research from GlobalData, "NanoString Technologies, Inc. - Medical Equipment - Deals and Alliances Profile", is now available at Fast Market Research NanoString Technologies, Inc. (NanoString) is a provider of ...

    Comment?

  18. Market Report, "Partek Incorporated - Pharmaceuticals & Healthcare -...Read the original story

    Feb 11, 2015 | PR-inside.com

    ... Inc., Applied Biosystems, Illumina, Fluidigm, Ingenuity Systems, IO Informatics, Ion Torrent, and NanoString Technologies. Partek is headquartered in Saint Louis, Missouri, the US. Full Report Details at - www ...

    Comment?

  19. New Market Research Report: NanoString Technologies, Inc. -...Read the original story

    Feb 11, 2015 | PR-inside.com

    NanoString Technologies, Inc. is a provider of provider of life science tools for translational research and molecular diagnostics. NanoString's technology enables a broad spectrum of basic research and translational medicine applications, such as biomarker discovery and validation.

    Comment?

  20. Breast Cancer Tests Betray 'Precision Medicine' BrandingRead the original story w/Photo

    Feb 3, 2015 | Forbes.com

    ... results of the three - Genomic Health's Oncotype DX , Agendia's Mammaprint and Prosigna from nanoString Technologies - often disagree. differ in the technological platforms used for assessment of gene expression, in the number of genes and in the ...

    Comment?